Literature DB >> 20630904

Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study.

V M Anderson1, L K Fisniku, Z Khaleeli, M M Summers, S A Penny, D R Altmann, A J Thompson, M A Ron, D H Miller.   

Abstract

BACKGROUND: In multiple sclerosis (MS), demyelination and neuroaxonal damage are seen in the hippocampus, and MRI has revealed hippocampal atrophy.
OBJECTIVES: To investigate and compare hippocampal volume loss in patients with relapsing-remitting MS (RRMS) and primary progressive MS (PPMS) using manual volumetry, and explore its association with memory dysfunction.
METHODS: Hippocampi were manually delineated on volumetric MRI of 34 patients with RRMS, 23 patients with PPMS and 18 controls. Patients underwent neuropsychological tests of verbal and visuospatial recall memory. Linear regression was used to compare hippocampal volumes between subject groups, and to assess the association with memory function.
RESULTS: Hippocampal volumes were smaller in MS patients compared with controls, and were similar in patients with RRMS and PPMS. The mean decrease in hippocampal volume in MS patients was 317 mm(3) (9.4%; 95% CI 86 to 549; p = 0.008) on the right and 284 mm(3) (8.9%; 95% CI 61 to 508; p = 0.013) on the left. A borderline association of hippocampal volume with memory performance was observed only in patients with PPMS.
CONCLUSION: Hippocampal atrophy occurs in patients with RRMS and PPMS. Factors additional to hippocampal atrophy may impact on memory performance.

Entities:  

Mesh:

Year:  2010        PMID: 20630904     DOI: 10.1177/1352458510374893

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  17 in total

Review 1.  Neuroimaging in multiple sclerosis: neurotherapeutic implications.

Authors:  Nancy L Sicotte
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

Review 2.  The role of advanced magnetic resonance imaging techniques in primary progressive MS.

Authors:  Maria A Rocca; Martina Absinta; Massimo Filippi
Journal:  J Neurol       Date:  2011-08-04       Impact factor: 4.849

3.  Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.

Authors:  Kristen A Rahn; Crystal C Watkins; Jesse Alt; Rana Rais; Marigo Stathis; Inna Grishkan; Ciprian M Crainiceau; Martin G Pomper; Camilo Rojas; Mikhail V Pletnikov; Peter A Calabresi; Jason Brandt; Peter B Barker; Barbara S Slusher; Adam I Kaplin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

Review 4.  Risk factors for and management of cognitive dysfunction in multiple sclerosis.

Authors:  Ralph H B Benedict; Robert Zivadinov
Journal:  Nat Rev Neurol       Date:  2011-05-10       Impact factor: 42.937

5.  Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis.

Authors:  Hanneke E Hulst; Menno M Schoonheim; Stefan D Roosendaal; Veronica Popescu; Lizanne J S Schweren; Ysbrand D van der Werf; Leo H Visser; Chris H Polman; Frederik Barkhof; Jeroen J G Geurts
Journal:  Hum Brain Mapp       Date:  2011-09-06       Impact factor: 5.038

6.  Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.

Authors:  R Sacco; A Bisecco; D Corbo; M Della Corte; A d'Ambrosio; R Docimo; A Gallo; F Esposito; S Esposito; M Cirillo; L Lavorgna; G Tedeschi; S Bonavita
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

Review 7.  Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.

Authors:  Shumita Roy; Ralph H B Benedict; Allison S Drake; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

8.  Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease.

Authors:  Marina O Ziehn; Andrea A Avedisian; Shannon M Dervin; Elizabeth A Umeda; Thomas J O'Dell; Rhonda R Voskuhl
Journal:  J Neurosci       Date:  2012-09-05       Impact factor: 6.167

9.  Brain Volume Changes in Patients with Acute Brain Dysfunction Due to Sepsis.

Authors:  Günseli Orhun; Erdem Tüzün; Başar Bilgiç; Perihan Ergin Özcan; Serra Sencer; Mehmet Barburoğlu; Figen Esen
Journal:  Neurocrit Care       Date:  2020-04       Impact factor: 3.210

10.  Neuronal hibernation following hippocampal demyelination.

Authors:  Selva Baltan; Safdar S Jawaid; Anthony M Chomyk; Grahame J Kidd; Jacqueline Chen; Harsha D Battapady; Ricky Chan; Ranjan Dutta; Bruce D Trapp
Journal:  Acta Neuropathol Commun       Date:  2021-03-01       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.